Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




Spliceosomal Peptide P140 (IPP-201101) for Immunotherapy of Systemic Lupus Erythematosus
Link ID 12662
Title Spliceosomal Peptide P140 (IPP-201101) for Immunotherapy of Systemic Lupus Erythematosus
Url http://www.medscape.com/viewarticle/585496?src=rss
Description Immunotherapy agent safe for lupus patients in clinical trial
ARTHRITIS & RHEUMATISM Research News Alerts
Category Articles > Rheumatology
Keywords
Date Jan 22, 2009
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Rheumatology
1. Characterisation of the Cannabinoid Receptor System in Synovial Tissue and Fluid in Patients With Os
  Pre-clinical and clinical studies have demonstrated that cannabis-based drugs have therapeutic potential in inflammatory diseases, including rheumatoid arthritis and multiple sclerosis.
Arthritis Research & Therapy
Category:   Articles > Rheumatology


2. Study Shows RA Patients and Doctors Differ on Disease Severity Assessment
  How differently do doctors and patients view symptoms of rheumatoid arthritis? Arthritis Care Research News Alerts
Category:   Articles > Rheumatology


3. Diagnosis of Pulmonary Arterial Hypertension in a Patient With Systemic Sclerosis
  Rapid-onset dyspnea on exertion is presented in a 42-year-old woman with limited cutaneous systemic sclerosis. What are the challenges of diagnosing pulmonary arterial hypertension in this patient?
Nature Clinical Practice Rheumatology
Category:   Articles > Rheumatology


4. The Spectrum of Autoinflammatory Diseases: Recent Bench to Bedside Observations
  Progress in understanding of autoinflammatory syndromes and how they have triggered the exploration of the role of innate immunity in common rheumatologic diseases is reviewed.
Current Opinion in Rheumatology
Category:   Articles > Rheumatology


5. B-Cell Depletion With Rituximab: A Promising Treatment for Diffuse Cutaneous Systemic Sclerosis
  Encouraging data is presented on the effects of rituximab in patients with diffuse cutaneous systemic sclerosis nonresponsive to cyclophosphamide. Arthritis Research & Therapy
Category:   Articles > Rheumatology




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS